BERNS PAUL L

OtherDirectorPrimarily LYEL

100% buying0% selling

Total Trades

1 buys · 1 sells

Total Bought

$12.50M

Total Sold

$34.46K

Companies

Buy Win Rate

—

insufficient data

Avg Buy Return*

-38.93%

Best buy (vs current price)

LYEL — bought $12.50M at $25.61, +-38.9% since (Mar 6, 2026)

Active

Feb 17, 2026 → Mar 6, 2026

Trade Volume by Year

Buy Sell

Top Traded Sectors

Pharmaceutical Preparations1

Biological Products, (No Diagnostic Substances)1

Most-Traded Stocks

Filters


LYELLyell Immunopharma, Inc.	1	1B / 0S	$12.50M
NMRANeumora Therapeutics, Inc.	1	0B / 1S	$34.46K

Trade History

Filters


Mar 6, 2026	LYEL	BUY	488,090	$25.61	$12.50M	-38.9%
Feb 17, 2026	NMRA	SELL	9,819	$3.51	$34.46K	—

*Return = current share price vs the insider’s purchase price (buys only). Not the insider’s realized return. Informational only — not investment advice.